Intensification of blood pressure lowering therapeutics based on diuretics versus usual management for uncontrolled hypertension in patients with moderate to severe chronic kidney disease (THINK): protocol for an open label, two-parallel group, cluster randomised controlled, superiority, phase 3 trial
- DOI
- 10.1136/bmjopen-2026-122192
- Published
- 2026-09
- Container
- BMJ Open
- Publisher
- BMJ
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1136/bmjopen-2026-122192,
title = {Intensification of blood pressure lowering therapeutics based on diuretics versus usual management for uncontrolled hypertension in patients with moderate to severe chronic kidney disease (THINK): protocol for an open label, two-parallel group, cluster randomised controlled, superiority, phase 3 trial},
author = {Floriane Le Vilain-Abraham and Jean-Michel Halimi and Patrick Rossignol and Maurice Laville and Michel Azizi and Bénédicte Stengel and Valentin Maisons and Agnès Rouzès and Agnès Caille and Bénédicte Sautenet},
year = {2026},
journal = {BMJ Open},
doi = {10.1136/bmjopen-2026-122192},
url = {https://doi.org/10.1136/bmjopen-2026-122192}
}RIS
TY - JOUR TI - Intensification of blood pressure lowering therapeutics based on diuretics versus usual management for uncontrolled hypertension in patients with moderate to severe chronic kidney disease (THINK): protocol for an open label, two-parallel group, cluster randomised controlled, superiority, phase 3 trial AU - Floriane Le Vilain-Abraham AU - Jean-Michel Halimi AU - Patrick Rossignol AU - Maurice Laville AU - Michel Azizi AU - Bénédicte Stengel AU - Valentin Maisons AU - Agnès Rouzès AU - Agnès Caille AU - Bénédicte Sautenet PY - 2026 JO - BMJ Open DO - 10.1136/bmjopen-2026-122192 UR - https://doi.org/10.1136/bmjopen-2026-122192 ER -
APA
Vilain-Abraham, F. L., Halimi, J., Rossignol, P., Laville, M., Azizi, M., Stengel, B., Maisons, V., Rouzès, A., Caille, A., & Sautenet, B. (2026). Intensification of blood pressure lowering therapeutics based on diuretics versus usual management for uncontrolled hypertension in patients with moderate to severe chronic kidney disease (THINK): protocol for an open label, two-parallel group, cluster randomised controlled, superiority, phase 3 trial. BMJ Open. https://doi.org/10.1136/bmjopen-2026-122192
Source records
- crossref · retrieved 2026-09-25T10:59:13.240Z